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In this paper, we will try to cover three questions about orthotopic liver 
transplantation, that is to say about liver replacement. The first question is 
what are the indications for hepatic transplantation? Second, what have 
been the results? Third, what are the prospects for future improvement? 
In Figure 1 is depicted a reminder of what exactly is orthotopic liver 
transplantation. With this operation the diseased native liver is removed, 
creating a space into which to accommodate the cadaveric graft. Orthotopic 
liver transplantation is often difficult, mainly because of the liver pathology 
that essentially always creates severe portal hypertension and extensive 
venous collaterals. Thus, removal of the native liver may be an extremely 
formidable undertaking. Revascularization of the graft is performed in as 
anatomically normal a way as possible, anastomosing the portal vein and 
hepatic artery end to end and reconstructing the vena cava above and below 
the liver. 
By far the most unsatisfactory aspect of this operation has been biliary 
duct reconstruction. In most of our cases, we have anastomosed the gall-
bladder to the duodenum after ligating the distal common duct. This method 
has real advantages under conditions of immu80suppression because it can 
be performed without stents and drains. However, there have been a number 
of lethal complications with these cholecystoduodenostomies, a point to 
which we will return later. 
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Fig. 1. - Orthotopic liver transplantation;the recipient operation. In most recent 
cases, cholecystoduodenostomy has been performed for biliary drainage as 
shown. c.a. = celiac axis; C.d. = common duct; G.B. - gall-bladder; H.a. = 
hepatic artery; l.V.c. = inferior vena cava; P.V. = portal vein; S.m.a. = su-
perior mesenteric artery. A. The kind of arterial anastomosis most commonly 
used. The homograft celiac axis or common hepatic artery is attached to the pro-
per or common hepatic artery of the recipient B. Arterial reconstruction of two 
homograft arteries. The vessels are indiv.idually anastomosed to the branches of 
the recipient proper hepatic artery. C. Anastomosis of the homograft aorta to the 
recipient aorta. The variation was used in a 16-month old recipient because of 
the double arterial supply to the transplanted liver. (By permission of Ann. Surg. 
168 : 392, 1968.) 
INDICATIONS FOR ORTHOTOPIC TRANSPLANTATION 
Hepatic Malignancy 
With these preliminary remarks we will now turn to the first question, that 
about the indications for operation. At the beginning, we thought that the 
ideal reason for liver replacement would be primary hepatic malignancies, 
including hepatoma. An example of the kind of extensive hepatoma we 
trefted in the early trials is shown in Figure 2. Our enthusiasm was quickly 
dampene<;l by a repetitive experience which we will illustrate for you with a 
single case. 
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Fig. 2. - The hepatoma and remaining liver excised from a 29 year old woman at 
the time of orthotopic t ransplantation. The operative specimen weighed 10 kg 
(By pe rmission of W. B. Saunders Co. , 1969) . 
In Figure 3 is the chest x-ray of a J 5-year-old boy a few weeks after 
successfuJ orthotopic liver transpJantation for a gigantic hepatoma. There is 
already a small puJmonary metastasis by 29 days. He died 143 days after 
operation with his lungs almost replaced by metastases. During the same 
interval, his new liver was similarly invaded as could be followed with serial 
scans (Fig. 4). There was evidence of metastases in the homograft at all 
times after 3 months. 
With the destruction of his liver he became secondarily jaundiced (Fig. 5) 
and finally died of combined hepatic and pulmonary insufficiency. At 
autopsy, his lungs were a mass of tumor. The same was true of the 
transplanted liver to an extent that only a remnant of normal hepatic tissue 
remained. We have had a half-dozen other so-called successful liver 
transplantations with subsequent widespread metastases and, in fact, three of 
our patients died beyond one year post-transplantation of this complication. 
It is a bit early to conclude once and for all that livcr transplan-
tation cannot be used to treat hepatoma, as can also be illustrated by 
another case. In Figure 6 is thc liver of a child with biliary atresia in 
which was found a small 2 cm he patoma as an incidental pathologic 
feature . The child has a perfect result without evidence of tumor recur-
rence more than 2 years later. Long survival after liver replacement for 
hepatoma has also been reported by CaIne of Cambridge, Daloze of Montreal 
and Fortner of New York. Nevertheless, we personaly would prefer not 
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·Fig. J. The extremely rapid development of pulmonary metastases in a patient 
whose indication for liver replacement was hepatoma. A. The chest is clear six days after 
transplantation. B. Twenty-nine days postoperative. Two metastases are visible in 
the lower left lung field (arrows). C. Five days later the tumor deposits previously 
seen have grown in size (horizontal arrows) and a third Focus is now present in the 
right upper iobe (vertical arrow). D. Forty-four days. Only 10 days have 
elapsed since the last examination. Metastatic growths are scattered throughout the 
lungs (arrows). E. Seventy-four days postoperative. F. Four months after operation . 
Transient dyspnea was first noticed a few days later. The patient died of pulmonary 
insufficiency 143 days after transplantation (By permission of W.B. Saunders Co., 1969). 
A 8 c o 
Fig . 4. - Destruction of a hepatic homograft by tumor recurrence, as demonstrated 
by serial technetium I iver scans . A. 68 days - The scan appears normal. B. 94 days-
The patient had become jaundiced. Hepatomegaly is evident. C. 101 days - MUltiple 
areas of poor isotope concentration are now visible. D. III days - The process has 
continued its rapid progression. By the time of death one month later, the homograft 
was almost completely replaced by tumor (By permission of W.B. Saunders Co, 1969). 
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Fig . 5_ -- The manifestations of the invasion and nearly complete dest.ruction of 
an orthotop ic liver homograft by recurrent hepatoma. The sporadic large doses 
of intravenous predni solone were given because of the possibility that the de-
teriorat.ing liver function was due to delayed rejection. At autopsy almost all the 
transplanted hepatic tissue was replaced by tumor. The liver scans of this patient 
shown in Figure 4 are indicated by the lettered arrows (A-OJ. The normal range 
for Bessey-Lowry (B-U alkaline phosphatase llnits is I to 3. The normals for the 
SGOT and SGPT units at this age are 60 to 100 and 5 to 35. respectively. (By 
permission of W. B. Saunders Co .. 1969.) 
Fig . 6. -- T he liver removed from a child with biliary atresia at the time of orthotopic 
hepatic transplantation. Note the 2 em hepatoma (arrow) which was an incidental 
finding in the specimen. 
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to do more hepatomas at this time since the high incidence of metastases 
(80 % in our hands) has beclouded the kind of conclusions that must be 
reached in evaluating any new procedure. 
It has seemed possible that the outlook might be less gloomy if the 
malignant tumor were some kind other than a hepatoma. It would not be 
surprising if non-resectable cholangiocarcinomas would be good candidates. 
Then there are the rare neoplasms of which the gross specimen in 
Figure 7 is an example with widespread multifocal primaries. This liver 
Fig. 7. - Macroscopic appearance of the liver excised at the time of hepatic transplan-
tation of the indication of hemangioendothelial sarcoma. 
was taken from a 52-year-old man who had a hemangioendothelial sarcoma. 
The neoplasm kills with incredible swiftness, usually within a few weeks 
and by intraabdominal hemorrhage or the development of hepatic insuffi-
cienry rather than by spread. In the summer of 1971, we treated this 
patient with orthotopic liver transplantation. The histopathologic character 
of the growth showed nearly normal hepatic cells and malignant Kupffer 
cells. 
Postoperatively, the bilirubin fell from 40 to near normal along with an 
improvement in other liver functions (Fig. 8). Then the patient survived 
a severe rejection which was eventually completely reversed. After 
achieving nearly normal function for more than 3 months, this patient also 
. developed widespread pulmonary metastases, as well as extensive recurrence 
in his liver graft. Thus, we encountered here one more example of the usual 
futility of treating hepatic malignancy with hepatic transplantation. 
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We draw your attention to the fact that one of the immunosuppressive 
agents used for this patient was cyclophosphamide rather than azathioprine 
(Fig. 8). Cyclophosphamide is, itself, one of the most widely used. of the 
anti -cancer chemotherapeutic drugs. It is also one of the best 
immunosuppressants. In addition, heterologous ALG and prednisone were 
used. 
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Fig. 8. - The early course of a 52 year old male who had total liver repla-
cement as treatment for a hemangioendothelial sarcoma. This rare liver tumor 
usually causes death from fulminating hepatic failure in a few weeks or months, 
but it does not commonly metastasize. After transplantation, there was a severe 
rejection crisis. The protracted thrombocytopenia postoperatively is often noted 
after liver transplantation and is probably due to thrombocyte sequestration in 
the homograft. ALG - horse anti-lymphocyte globulin; SGOT - serum glutamic 
oxalacetic transaminase in international units; and ARROW - 625 milligrams of 
methyl prednisolone intravenously (By permission of Surg. Gynec. Obstet. 133: 
9S1, 1971). 
Benign Hepatic Disease 
Starting in such a negative way about the indications for liver replacement 
is one way of indicating that the important future of hepatic transplantation 
is for the treatment of benign hepatic disease. There is little point in listing 
the diseases since the end-stage is much the same. In fact, our general 
position now is that anyone under 40 who is not a sociopath and who is 
dying of hepatic insufficiency should theoretically be a candidate for liver 
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transplantation. The most common diagnoses would, of course, be cirrhosis, 
chronic aggressive hepatitis, and biliary atresia. 
T he longest survivor in the world to date after liver transplantation was a 
boy whose operation was in July, 1968. His early course is shown in Figure 
9. There was a very minimal rejection crisis in the second post-operative 
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Fig. 9. - The early course of a 4 year old child who survived for 3 1/2 yea rs 
after orthotopic liver transplantation for the indication of biliary at resia . Note 
the rejection episodes at I month and 2 1/2 months, which were easily co ntrol-
led. (By permission of W . B. Saunders C o., 1969.) 
month. His liver was biopsied at 3 years and found to be almost normal. 
Then suddenly just before Christmas he developed a violent hepatitis for 
which the most likely etiologic explanation was the Herpes or chicken pox 
virus (virology and pathology studies are still in process). He died of acute 
hepatic insufficiency a few days later after a total survival of 3 1/2 years, 
of which almost all was spent in good health . 
In Figure 10 is the liver of anothe r patient with benign disease. Th is child 
was suffering from Wilson's disease which led to cirrhosis and finally 
profound liver failure. After operation, he had a grave rejection crisis which 
eventually reversed and with an ultimately good result now after more than 
2 I /2 years (Fig. I I) . He has returned to his home in Ohio where he now 
goes to school. 
As all of you know, Wilson's disease is an inborn error of metabolism of 
which the precise pathophysiology has never been worked out. The essential 
biochemical finding is the deposition of copper in all tissues, including the 
liver and brain. The characteristic Kayser-Fleischer rings by which the 
ophtalmologist can make the diagnosis are nothing more than copper 
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Fig. 10 . - The nalive liver of a child whose hepatic failure was caused by Wil son's 
d isease . The recipient's postoperative course is shown in Figure I J. 
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FiR. J I. - Postoperative course of an II year ol d recipient of an orthotopic li-
ver homograft for cirrhosis secondary to Wilson's disease, A severe rejection cri-
sis beginning about 3 weeks post-transplantation eventually reversed and hepatic 
function has been essentially nor mal since the sixth postoperative month. The 
patient remains in good health 2 J /2 years after operation. 
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accumulations in the cornea. The information we have about this case makes 
us believe that this copper accumulation is not recurring post-transplantation 
and that, on the contrary, copper metabolism is probably remaining normal. 
After operation, there was a massive cupriuresis which lasted for almost 6 
months (Fig. 12). At this time, the liver was biopsied and then a biopsy was 
repeated after I 1 /2 years. On both occasions the liver" copper content was 
entirely normal. 
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Fig. 12. - Urinary excretion of copper after orthotopic liver transplantation for 
Wilson's disease. Following operation there was a massive cupriuresis lasting 6 
months. A secondary peak of copper excretion occurred in response to a 3-day 
test course of penicillamine. (By permission of Lancet 1 : 505, 1971). 
We have treated another patient with Wilson's disease, this time almost a 
year ago. In this second patient the main indication for proceeding was 
extremely severe neurologic involvement that was not controlled by 
penicillamine therapy. In fact, the recipient was so neurologically crippled 
that he had some respiratory distress. The early course of the patient is 
shown in Figure 13. It is a complicated graph but one from which some 
important points can be illustrated. First, the immunosuppressive treatment 
was again with cyclophosphamide (or Cytoxan) instead of azathioprine 
(Imuran) ; in addition to the cyclophosphamide, horse ALG and prednisone 
were administered. Second, rejection probably never occurred in this 
patient. There was a marked deterioration of hepatic function in the second 
post-operative month at which time the boy became jaundiced and had rises 
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Fig. 13. - Triple drug therapy with cyclophosphamide, prednisone and horse 
antilymphocyte globulin (ALG) in a patient who had an orthotopic liver trans-
plantation for Wilson's disease. Rejection has never been diagnosed postoperati-
vely. The temporary deterioration in hepatic function in the second postoperative 
month was accompanied by Australia antigenemia detected by the complement 
fixation (CF) technique and consequently was thought to be a manifestation of 
serum hepatitis. (By permission of Surg. Gynec. Obstet. 133: 981, 1971). 
in his transaminases, However, this was probably not rejection for, at the 
same time, he developed Australia antigenemia with prodigious increases in 
his complement fixation titers. Immunosuppression was not intensified and 
he spontaneously recovered, The reason for mentioning this second point is 
that we now realize how many factors other than rejection can cause 
deterioration of hepatic homograft function. The most important of these 
non-immunologic complications are serum hepatitis, such as demonstrated in 
Figure 13, biliary duct obstruction, which we will return to later since it is a 
dreaded complication, and drug-induced hepatotoxicity. 
This concludes our remarks about indications. If we have not made our 
position clear, it can be summarized with one sentence. We believe the 
situation is completely analogous to that in renal transplantation in which 
field benign disease is also the prime indication for treatment, 
CLINICAL RESULTS 
We will now pass to the second question, namely that of the results 
obtained, Between the spring of 1963 and July, 1967,7 attempts at 
orthotopic liver transplantation were made in Denver. All failed with death 
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in 21 days or less. Our own experience, including these cases and all 
subsequent ones until a little more than one year ago, has consisted of 36 
cases. Survival of at least one year was obtained in 10 of these 36 recipients, 
or 28 % (Table I). The record was not disgraceful since all these patients 
were doomed to early death, but it can certainly stand improvement. 
Even after one year, 7 patients were lost for the reasons and at the times 
you see in Table 2. The most common cause of late failure was 
Fable I. - 36 orthotopic transplantations 
One year Survival 
10/36 (28 %) 
Ta/JIe 2. - 10 one·year survivors after orthotopic transplantation 
ALIVE 3/10 -- I 1/6 to 3 1/3 years 
DIED 7/10 -- I to 3 1/2 years 
12 months -- Cancer 
12 months -- Serum hepatitis, liver failure 
14 months -- Cancer 
15 months -- Cancer 
15 months -- Rejection, liver failure 
30 months -- Rejection, liver failure 
42 months -- Hepatitis, liver failure 
carcinomatosis, accounting for 3 deaths after one year. Serum hepatitis 
caused one late death and chronic homograft rejection was responsible for 
two others. As already mentioned, the death that occurretl at 3 I /2 years 
seemed due to some kind of hepatitis, possibly caused by the Herpes virus, 
although this has not been proved. 
The whole question of serum hepatitis in transplant patients is just 
beginning to unfold but there is plenty of reason to know that it is a 
potentially serious matter. Liver disease and, specifically, hepatitis in renal 
transplant patients is a very common complication, occurring in 10-20 % of 
all kidney recipients in our center. The incidence of serum hepatitis in our 
liver patients is even higher and we have already shown you one example of 
this. In view of these observations, is there any hope of treating lethal serum 
hepatitis with liver transplantation? We do not know the answer to the 
question. However, it is worth telling of an extraordinary patient whose 
reason for transplantation was chronic aggressive hepatitis, Australia antigen 
positive. She was in profound hepatic failure. 
Transplantation was carried out more than 18 months ago. The Australia 
antigen became negativt> for almost 2 months and then returned to positive 
at the same time as a clinical bout of acute serum hepatitis (Figure 14). She 
recovered from this but her Australia antigen has remained positive to the 
present. A re·peat biopsy 14 months after transplantation revealed recurrence 
of the chronic aggressive hepatitis in her transplanted liver. 
72 
Liver transplantation 
AG + + + + + + - .-- - -
IEOP 
TITER ~i+-_____ ---l~ ___ ===---,J ~ __ ~---~~~~_ 
CF t,ii: 
TITER 
ACA 
TITER 
~i+---- -----m 
Jt------ +----"==-
",>0 
SGOT 
(IU) 
'000 
ALKALINE 
~K~~====~~~~ ________ -=-=L-__ __~~=_~~ 
PHOSPHATASE • 
!S-L l,/NITSI 
BILIRUBIN 
.... %) 
TOTAL-
CONJUGATED---
SERUM 
~t;Koq~fk 4 -----------__ 
ALBUMIN .".".". 
"Y GLOBULlN---
Fig. J 4. - Orthotopic hepatic transplantation for liver failure caused by chronic 
aggressive hepatitis. The Australia antigen, which had been detectable in mul-
tiple serum samples for one year before operation, disappeared within hours after 
removal of her own liver. However, the Au antigen reappeared in her blood 
stream about 2 months post-transplantation at a time when she developed a cli-
nical episode of hepatitis. 
Nevertheless, her health remains satisfactory and, for her, meaningful life 
has been prolonged. In view of this, the issue of whether more similar 
patients should be treated is perhaps more of a philosophical than a medical 
one. 
FUTURE PROSPECTS 
We will now turn to the third question posed at the outset, namely the 
prospects of improving the outlook after liver replacement, and assuming 
that only reasonable candidates with non-malignant disease are accepted. 
First, we are convinced that one of the real Achilles heels of this procedure 
is ineffective reconstruction of the biliary duct. 
With cholecystoduodenostomy, we .have had obstruction at or near the 
junction of the common and cystic ducts. The nature of the lesion can be 
appreciated by the kind of operative cholangiogram that is performed with a 
Foley catheter inserted into the gallbladder (Fig. 15). The kind of 
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Fig . 15. - Cholangiography of a hepatic homograft in which biliary recons-
truction was with cholecystoduodenostomy. LEFT - Technique of dye injection 
through a duodenotomy and the anastomosis. RIG HT - Obstructed duct system. 
Despite re-exploration and conversion to choledochoduodenostomy, the recipient 
died of uncontrolled sepsis 46 days after transplantation. 
obstruction of the duct system shown in Figure 15 was corrected in 2 cases 
at reoperation but too late. All 4 of the patients with this lesion died. , 
A crucial question in cas(l.S like that shown in Figure 15 concerns the 
reason for obstruction at or near the cystic duct. In four recent cases of this 
kind in which specimens became available for histopathologic examination, 
Dr. K.A. PORTER of London has made some intriguing observations. He 
found that the extrahepatic ducts had ulcerations and edema even though 
there was little or no evidence of active rejection. The epithelial cells of 
these ducts were swollen and had intranuclear inclusions resembling those of 
cytomegalovirus (CMV). Thus, the very real possibility has to be kept open 
that this variety of biliary duct obstruction has an infectious etiology. 
Whatever its cause, it is possible that this kind of biliary obstruction 
could be avoided if the small caliber cystic duct were not made part 
of the cori.duit for bile drainage. In 4 recent cases of liver transplan-
tation, we have performed choledochoduodenostomy by the technique 
shown in Figure 16 and 17 in which the common duct is passed 
through a short duodenal tunnel and then everted with a few sutures. 
Unfortunately, one of these patients died after disruption of the choledo-
choduodenostomy and the development of biliary peritonitis. As a 
consequence ot this sad experience we have reversed ourselves again ana are 
inclined to perform cholecystoduodenostomy as a primary procedure. 
However, we wouJd promptly re-explore with the slightest ' suspicion of 
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Fig. 16. - Technique of choledochoduodenostomy. After opening the duodenum 
(A), a submucosal tunnel is created (B, C) through which the homograft common 
bile duct is passed (El. 
mechanical obstruction and then convert to the type of anastomosis shown 
in Figures 16 and 17 or to some other alternative hookup. 
In addition to improving the technical performance of liver 
transplantation, we believe it is important to try to use immunosuppressive 
agents that have low hepatotoxicity and with this objective we have switched 
since early last year to cyclophosphamide instead of azathioprine for all our 
fresh cases. The usefulness of this major change will require much more 
evaluation before it can be generally recommended. However, we would like 
to tell you now that our primary treatment in the next cases will be with 
cyclophosphamide, prednisone and ALG. After 3 to 8 weeks, we will tMn 
switch from cyclophosphamide to maintenance azathioprine. This switch-over 
technique has already had an extensive and highly satisfactory evaluation 
with laboratory experiments and after human renal transplantation. 
SUMMARY 
A brief answer will now be given to each of the three questions posed at 
the beginning. First, the prime indication for liver replacement is nOl1-
neoplasic hepatic disease. Second. the one-year survival in our clinic for all 
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Fig. 17. - Choledochoduodenostomy (continued). The homograft bile duct is se-
cured in place with four fine sutures (G, H, I) in sucQ a way as to create an 
everting nipple (1). 
patients treated up to one year ago was about 30 %. Third, there should be 
considerable optimism that this survival can be improved by a better 
technical performance and especially by improved biliary duct drainage. 
Some recent developments in immunosuppression in which 
cyclophosphamide has been to replace or supplement azathioprine may also 
be beneficial. 
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